Anti-Allergic Drugs Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

CHAPTER 1. Industry Overview of Anti-Allergic Drugs Market

1.1. Definition and Scope

1.1.1. Definition of Anti-Allergic Drugs

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Anti-Allergic Drugs Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Anti-Allergic Drugs Market By Type of Allergy

1.2.3. Anti-Allergic Drugs Market By Medication

1.2.4. Anti-Allergic Drugs Market By End-Users

1.2.5. Anti-Allergic Drugs Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data End-Users

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Anti-Allergic Drugs Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Anti-Allergic Drugs Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Anti-Allergic Drugs Market By Type of Allergy

4.1. Introduction

4.2. Anti-Allergic Drugs Revenue By Type of Allergy

4.2.1. Anti-Allergic Drugs Revenue (USD Million) and Forecast, By Type of Allergy, 2018-2030

4.2.2. Food Allergy

4.2.2.1. Food Allergy Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.3. Drug Allergy

4.2.3.1. Drug Allergy Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.4. Skin Allergy

4.2.4.1. Skin Allergy Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.5. Insect Allergy

4.2.5.1. Insect Allergy Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.6. Indoor and Outdoor Allergy

4.2.6.1. Indoor and Outdoor Allergy Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.7. Latex Allergy

4.2.7.1. Latex Allergy Market Revenue (USD Million) and Growth Rate (%), 2018-2030

4.2.8. Others

4.2.8.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 5. Anti-Allergic Drugs Market By Medication

5.1. Introduction

5.2. Anti-Allergic Drugs Revenue By Medication

5.2.1. Anti-Allergic Drugs Revenue (USD Million) and Forecast, By Medication, 2018-2030

5.2.2. Corticosteroids

5.2.2.1. Corticosteroids Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.3. Decongestants

5.2.3.1. Decongestants Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.4. Epinephrine

5.2.4.1. Epinephrine Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.5. Allergen Immunotherapy

5.2.5.1. Allergen Immunotherapy Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.6. Antihistamines

5.2.6.1. Antihistamines Market Revenue (USD Million) and Growth Rate (%), 2018-2030

5.2.7. Others

5.2.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 6. Anti-Allergic Drugs Market By End-Users

6.1. Introduction

6.2. Anti-Allergic Drugs Revenue By End-Users

6.2.1. Anti-Allergic Drugs Revenue (USD Million) and Forecast, By End-Users, 2018-2030

6.2.2. Hospitals

6.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.3. Ambulatory Clinics

6.2.3.1. Ambulatory Clinics Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.4. Clinics

6.2.4.1. Clinics Market Revenue (USD Million) and Growth Rate (%), 2018-2030

6.2.5. Others

6.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030

CHAPTER 7. North America Anti-Allergic Drugs Market By Country 

7.1. North America Anti-Allergic Drugs Market Overview

7.2. U.S.

7.2.1. U.S. Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

7.2.2. U.S. Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

7.2.3. U.S. Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

7.3. Canada

7.3.1. Canada Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

7.3.2. Canada Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

7.3.3. Canada Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

7.4. North America PEST Analysis

CHAPTER 8. Europe Anti-Allergic Drugs Market By Country

8.1. Europe Anti-Allergic Drugs Market Overview

8.2. U.K.

8.2.1. U.K. Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

8.2.2. U.K. Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

8.2.3. U.K. Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

8.3. Germany

8.3.1. Germany Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

8.3.2. Germany Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

8.3.3. Germany Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

8.4. France

8.4.1. France Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

8.4.2. France Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

8.4.3. France Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

8.5. Spain

8.5.1. Spain Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

8.5.2. Spain Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

8.5.3. Spain Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

8.6. Rest of Europe

8.6.1. Rest of Europe Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

8.6.2. Rest of Europe Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

8.6.3. Rest of Europe Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Anti-Allergic Drugs Market By Country

9.1. Asia Pacific Anti-Allergic Drugs Market Overview

9.2. China

9.2.1. China Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

9.2.2. China Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

9.2.3. China Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

9.3. Japan

9.3.1. Japan Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

9.3.2. Japan Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

9.3.3. Japan Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

9.4. India

9.4.1. India Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

9.4.2. India Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

9.4.3. India Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

9.5. Australia

9.5.1. Australia Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

9.5.2. Australia Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

9.5.3. Australia Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

9.6. South Korea

9.6.1. South Korea Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

9.6.2. South Korea Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

9.6.3. South Korea Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

9.7.2. Rest of Asia-Pacific Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

9.7.3. Rest of Asia-Pacific Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Anti-Allergic Drugs Market By Country

10.1. Latin America Anti-Allergic Drugs Market Overview

10.2. Brazil

10.2.1. Brazil Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

10.2.2. Brazil Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

10.2.3. Brazil Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

10.3. Mexico

10.3.1. Mexico Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

10.3.2. Mexico Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

10.3.3. Mexico Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

10.4. Rest of Latin America

10.4.1. Rest of Latin America Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

10.4.2. Rest of Latin America Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

10.4.3. Rest of Latin America Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Anti-Allergic Drugs Market By Country 

11.1. Middle East & Africa Anti-Allergic Drugs Market Overview

11.2. GCC

11.2.1. GCC Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

11.2.2. GCC Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

11.2.3. GCC Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

11.3. South Africa

11.3.1. South Africa Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

11.3.2. South Africa Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

11.3.3. South Africa Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Anti-Allergic Drugs Revenue (USD Million) and Forecast By Type of Allergy, 2018-2030

11.4.2. Rest of Middle East & Africa Anti-Allergic Drugs Revenue (USD Million) and Forecast By Medication, 2018-2030

11.4.3. Rest of Middle East & Africa Anti-Allergic Drugs Revenue (USD Million) and Forecast By End-Users, 2018-2030

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Anti-Allergic Drugs Market

12.1. Anti-Allergic Drugs Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

12.2.2. New Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Anti-Allergic Drugs Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. Company Profile

13.1. Allergy Therapeutics

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Revenue (USD Million), 2021

13.1.3.2. Allergy Therapeutics 2021 Anti-Allergic Drugs Business Regional Distribution

13.1.4. Product/Service and Specification

13.1.5. Recent Developments & Business Strategy

13.2. Collegium Pharmaceutical

13.3. Genentech, Inc.

13.4. Strides Pharma Science Limited

13.5. McNeil Consumer Healthcare

13.6. Allergan, Plc.

13.7. Allergopharma GmbH & Co. KG.